Skip to main content
. 2022 Aug 22;14(1):72–80. doi: 10.1007/s13193-022-01622-7

Fig. 1.

Fig. 1

Patient classification: Group A (synchronous metastasis) — 23 cases (bone, 7; liver, 1; lung, 3; contralateral supraclavicular node, 3; opposite axillary metastasis, 9). Group B (locally recurrent carcinoma) — 26 cases. Group C (metachronous metastasis) — 61 cases (bone, 20; liver, 9; lung, 15; contralateral supraclavicular node, 12; opposite axillary metastasis, 4; subcutaneous metastasis, 1)